Patient Dies in Bristol Myers Squibb Autoimmune CAR-T Trial
A patient has died during a clinical trial of the investigational CAR-T therapy zolacabtagene autoleucel for multiple sclerosis.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The story so far
2 publishers have covered this in 4 articles since 23 Oct 2026. STAT published first, on 23 October at 18:55 UTC; MedPageToday.com - medical news for physicians followed 24h 24m later. The most recent article, from STAT, appeared on 27 October at 18:05 UTC.
Outlets reporting it: STAT, MedPageToday.com - medical news for physicians.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
How it unfolded
Every source in the order it published.
- STATSTAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial
- MedPageToday.com - medical news for physiciansPatient Death Reported in Multiple Sclerosis CAR-T Study
- STATSTAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more
- STATSTAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
Sources
Every article we clustered into this story. Headlines link to the publisher.
- STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down STAT
- STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more STAT
- Patient Death Reported in Multiple Sclerosis CAR-T Study MedPageToday.com - medical news for physicians
- STAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial STAT
In this story
- Bristol Myers Squibb